Protecting Health Care Workers During the COVID-19 Outbreak

Protecting Health Care Workers During the COVID-19 Outbreak:Qualitative Study of AYUSH Initiative

Preparing to deal with Covid-19 outbreak in Rajasthan, India, health care workers were given Ayurvedic Kadha (combination of ayurvedic herbal extracts) starting from the end of February 2020. Then, majority of these health care workers were put on front line managing screening, monitoring, quarantine and treating Covid 19 patients. This real-life study aimed to determine the experience of health care workers who had Ayurveda kadha before starting as front-line workers.

Study Overview

• Status: Completed
• Conditions: Covid-19
• Intervention / Treatment: Dietary supplement: Ayurvedic Kadha

• Study Type: Observational
• Enrollment (Actual): 52

Contacts and Locations

Study Locations

• India
  • Rajasthan
    • Jaipur, Rajasthan, India
      • Samta Ayurveda Prakoshtha

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 60 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Health care workers at front line of Covid-19 screening, treatment and management

Description

Inclusion Criteria:

• Health care workers posted in Covid-19 duties at front line
• Health workers who had Ayurveda herbs combination over for at least 10-days

Exclusion Criteria:

• No willing to consent
• inability to participate

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Physical Health	Self-reported health issues	From baseline to 30-days
Psychological Health	Self-reported psychological issues	From baseline to 30-days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Coping with distress	Self-reported coping with high demanding work in Covid-19 duties	From baseline to 30-days
Self-Help	Self reported self-help measures used	From baseline to 30-days

Collaborators and Investigators

• Sponsor: Aarogyam UK
• Collaborators: Samta Ayurveda Prakoshtha, India
• Investigators: Study Director: Jaydeep Joshi, Aarogyam UK; Study Chair: Neha Sharma, British Ayurvedic Medical Council (UK); Study Director: Parashar Sharma, Samta Ayurveda Prakoshtha, India; Principal Investigator: Sahil Singhal, Samta Ayurveda Prakoshtha, India

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2020
• Primary Completion (Actual): April 2, 2020
• Study Completion (Actual): April 2, 2020

Study Registration Dates

• First Submitted: May 13, 2020
• First Submitted That Met QC Criteria: May 13, 2020
• First Posted (Actual): May 14, 2020

Study Record Updates

• Last Update Posted (Actual): May 14, 2020
• Last Update Submitted That Met QC Criteria: May 13, 2020
• Last Verified: May 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: AU/SA/01

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No